Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/14045
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYang, Deying-
dc.contributor.authorZhao, Deqin-
dc.contributor.authorGong, Xufei-
dc.contributor.authorChen, Xinrui-
dc.date.accessioned2022-11-17T07:52:00Z-
dc.date.available2022-11-17T07:52:00Z-
dc.date.issued2017-09-20-
dc.identifier.citationYang, D., Zhao, D., Gong, X., & Chen, X. (2017). Effect of azithromycin and pefloxacin in treatment of acute enteritis based on clinical efficacy comparison. Pakistan Journal of Pharmaceutical Sciences, 30.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/14045-
dc.description.abstractThis paper aims to compare and analyze clinical efficacy of azithromycin and pefloxacin in treatment of acute enteritis. The 160 patients with acute enteritis were randomly divided into a study group (n=80) treated with azithromycin, and a reference group (n=80) treated with pefloxacin. We compared overall treatment efficiency (markedly, effective, invalid), clinical symptoms and signs remission time (antipyretic time, antidiarrheal time, symptoms and signs disappearance time), interleukin-6 and C-reactive protein concentration before and after treatment, adverse reactions rate (nausea, abdominal pain, headache, etc.). In comparison of overall treatment efficiency of the two groups, the results showed that the study group was significantly superior to the reference group (P<0.05). In comparison of clinical symptoms and signs remission time of the two groups, the study group were significantly shorter than the reference group (P<0.05). At the same time, in comparison of levels of interleukin-6 and C-reactive protein concentration after treatment, the study group was significantly superior to the reference group (P<0.05). There was no significant difference between the two groups in incidence of adverse reactions (P<0.05). The efficacy of azithromycin for acute enteritis is better than that of pefloxacin, and it can significantly reduce clinical symptom remission time. Moreover, safe and reliable, it has great value in clinical application.en_US
dc.language.isoenen_US
dc.publisherKarachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.en_US
dc.subjectAzithromycinen_US
dc.subjectpefloxacinen_US
dc.subjectacute enteritisen_US
dc.subjecttherapeutic effecten_US
dc.subjectcomparative analysisen_US
dc.titleEffect of azithromycin and pefloxacin in treatment of acute enteritis based on clinical efficacy comparisonen_US
dc.typeArticleen_US
Appears in Collections:No.5(Special), September, 2017

Files in This Item:
File Description SizeFormat 
5-SP-5870.htm192 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.